Hepy Biosciences Overview

  • Status
  • Private
  • Employees
  • 1
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Hepy Biosciences General Information


Manufacturer of a cancer care drug. The company develops a cancer drug that suppresses a certain enzyme activity in tumor responsible for its growth and for the development of secondary tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Nes Ziona
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hepy Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 12-Jan-2015 Completed Startup
To view Hepy Biosciences’s complete valuation and funding history, request access »

Hepy Biosciences Executive Team (2)

Name Title Board Seat Contact Info
Oded Livnah Professor
Nili Schutz Ph.D Chief Executive Officer
To view Hepy Biosciences’s complete executive team members history, request access »

Hepy Biosciences Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hepy Biosciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
FutuRx Accelerator/Incubator 000 0000 000000 0
To view Hepy Biosciences’s complete investors history, request access »